Sublingual Ketamine: An Option for Increasing Accessibility of Ketamine Treatments for Depression?
Clicks: 178
ID: 114201
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
178 views
29 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #74 of 273 articles by views in the journal of clinical psychiatry
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 273 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
In this letter to the editor, Drs Swainson and Khullar describe their experiences with use of sublingual ketamine in the clinical setting and argue that it may be an accessible alternative for appropriate patients.
| Reference Key |
swainson2020thesublingual
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Jennifer Swainson;Atul Khullar; |
| Journal | the journal of clinical psychiatry |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.